tumor

Glowing puzzle piece fitting into puzzle
Biotech

Gilead pens $1.5B Genhouse deal for synthetic lethal therapy

Gilead has secured another synthetic lethal therapy, handing $80 million upfront for a clinic-ready cancer drug from China’s Genhouse Bio.
James Waldron Feb 16, 2026 2:00pm
Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am
radiopharma radiopharmaceuticals

Sanofi $110M radioligand therapy hits main goal in ph. 2 trial

Oct 8, 2025 6:25am
layoffs cuts workforce reduction chairs boxes fired

BioNTech cuts 90 more US jobs as part of pipeline realignment

Aug 5, 2025 1:24pm
bird birds flying humingbirds

Hummingbird uses VISTA buzz to secure $290M pact for tumor drug

Jun 26, 2025 4:53am
Mosaic pattern collage

Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

Apr 24, 2025 10:00am